Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMID 19744568)

Published in Neuroimage on September 08, 2009

Authors

Mojtaba Zarei1, Brian Patenaude, Jessica Damoiseaux, Ciro Morgese, Steve Smith, Paul M Matthews, Frederik Barkhof, Serge A R B Rombouts, Ernesto Sanz-Arigita, Mark Jenkinson

Author Affiliations

1: FMRIB Centre, John Radcliffe Hospital, Oxford, UK. mojtaba@fmrib.ox.ac.uk

Articles citing this

A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage (2011) 6.60

Macrostructural alterations of subcortical grey matter in psychogenic erectile dysfunction. PLoS One (2012) 1.44

Automatic morphometry in Alzheimer's disease and mild cognitive impairment. Neuroimage (2011) 1.32

Robust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI data. PLoS One (2013) 1.15

Disrupted small-world brain networks in moderate Alzheimer's disease: a resting-state FMRI study. PLoS One (2012) 1.15

Diffusion tensor imaging reveals thalamus and posterior cingulate cortex abnormalities in internet gaming addicts. J Psychiatr Res (2012) 1.02

Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T. Neuroimage (2013) 0.98

Regional changes in thalamic shape and volume with increasing age. Neuroimage (2012) 0.97

Thalamic shape and connectivity abnormalities in children with attention-deficit/hyperactivity disorder. Psychiatry Res (2012) 0.96

Caudate atrophy and impaired frontostriatal connections are linked to executive dysfunction in temporal lobe epilepsy. Epilepsy Behav (2011) 0.92

Ventricular enlargement in new-onset pediatric epilepsies. Epilepsia (2011) 0.88

Kynurenines, neurodegeneration and Alzheimer's disease. J Cell Mol Med (2010) 0.87

Analysis of grey matter in thalamus and basal ganglia based on EEG α3/α2 frequency ratio reveals specific changes in subjects with mild cognitive impairment. ASN Neuro (2012) 0.86

Changes in thalamic connectivity in the early and late stages of amnestic mild cognitive impairment: a resting-state functional magnetic resonance study from ADNI. PLoS One (2015) 0.86

Compensating for thalamocortical synaptic loss in Alzheimer's disease. Front Comput Neurosci (2014) 0.85

Volumetric and shape analysis of thalamus in idiopathic generalized epilepsy. J Neurol (2013) 0.84

Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. Cereb Cortex (2014) 0.83

Fluid-attenuated inversion recovery hypointensity of the pulvinar nucleus of patients with Alzheimer disease: its possible association with iron accumulation as evidenced by the t2(*) map. Korean J Radiol (2012) 0.81

Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit. Brain (2016) 0.80

Fornix White Matter is Correlated with Resting-State Functional Connectivity of the Thalamus and Hippocampus in Healthy Aging but Not in Mild Cognitive Impairment - A Preliminary Study. Front Aging Neurosci (2015) 0.79

Structural alterations in brainstem of fibromyalgia syndrome patients correlate with sensitivity to mechanical pressure. Neuroimage Clin (2013) 0.79

Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers. Cortex (2014) 0.79

Structural and functional connectivity in traumatic brain injury. Neural Regen Res (2015) 0.78

Electroencephalogram and Alzheimer's disease: clinical and research approaches. Int J Alzheimers Dis (2014) 0.78

Thalamus parcellation using multi-modal feature classification and thalamic nuclei priors. Proc SPIE Int Soc Opt Eng (2016) 0.78

Thalamo-cortical connectivity: what can diffusion tractography tell us about reading difficulties in children? Brain Connect (2014) 0.77

Effects of acupuncture at HT7 on glucose metabolism in a rat model of Alzheimer's disease: an 18F-FDG-PET study. Acupunct Med (2015) 0.77

Thalamic shape abnormalities in antipsychotic naïve schizophrenia. Indian J Psychol Med (2013) 0.76

Seed Location Impacts Whole-Brain Structural Network Comparisons between Healthy Elderly and Individuals with Alzheimer's Disease. Brain Sci (2017) 0.75

Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease Patients. Front Aging Neurosci (2017) 0.75

Micro-structural white matter abnormalities in type 2 diabetic patients: a DTI study using TBSS analysis. Neuroradiology (2016) 0.75

Thalamus segmentation using multi-modal feature classification: Validation and pilot study of an age-matched cohort. Neuroimage (2017) 0.75

Articles by these authors

Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54

Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage (2006) 23.57

Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25

Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med (2010) 13.82

Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage (2009) 11.90

Common variants conferring risk of schizophrenia. Nature (2009) 10.37

Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A (2009) 9.19

Bayesian analysis of neuroimaging data in FSL. Neuroimage (2008) 9.10

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage (2002) 8.03

General multilevel linear modeling for group analysis in FMRI. Neuroimage (2003) 7.79

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet (2009) 7.16

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol (2004) 6.95

Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage (2004) 6.87

A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage (2011) 6.60

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med (2006) 5.20

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09

Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI. J Neurosci (2007) 5.03

Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. Radiology (2017) 4.99

Temporally-independent functional modes of spontaneous brain activity. Proc Natl Acad Sci U S A (2012) 4.44

Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum Brain Mapp (2005) 4.11

PML in a patient treated with dimethyl fumarate from a compounding pharmacy. N Engl J Med (2013) 4.02

The minimal preprocessing pipelines for the Human Connectome Project. Neuroimage (2013) 4.01

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet (2009) 3.92

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet (2011) 3.76

Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol (2007) 3.47

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol (2009) 3.42

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet (2007) 3.29

The role of ipsilateral premotor cortex in hand movement after stroke. Proc Natl Acad Sci U S A (2002) 3.27

Polarity-sensitive modulation of cortical neurotransmitters by transcranial stimulation. J Neurosci (2009) 3.25

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Lancet Neurol (2011) 3.16

Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex (2004) 3.03

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial. Lancet Neurol (2008) 3.01

Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc (2007) 3.00

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol (2008) 2.85

Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain (2007) 2.80

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology (2013) 2.77

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol (2011) 2.75

Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol (2010) 2.63

Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet (2010) 2.61

Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke (2005) 2.59

Correlation between motor improvements and altered fMRI activity after rehabilitative therapy. Brain (2002) 2.57

Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke (2008) 2.57

Evaluating the toxicity of airborne particulate matter and nanoparticles by measuring oxidative stress potential--a workshop report and consensus statement. Inhal Toxicol (2008) 2.53

An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab (2011) 2.52

Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ (2009) 2.51

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology (2005) 2.47

Advances in diffusion MRI acquisition and processing in the Human Connectome Project. Neuroimage (2013) 2.46

Semantic processing in the left inferior prefrontal cortex: a combined functional magnetic resonance imaging and transcranial magnetic stimulation study. J Cogn Neurosci (2003) 2.44

Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 2.44

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain (2002) 2.30

White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol (2005) 2.29

What motivates the adolescent? Brain regions mediating reward sensitivity across adolescence. Cereb Cortex (2010) 2.28

Adolescent risky decision-making: neurocognitive development of reward and control regions. Neuroimage (2010) 2.28

Evaluation of registration methods on thoracic CT: the EMPIRE10 challenge. IEEE Trans Med Imaging (2011) 2.24

Neuroscience thinks big (and collaboratively). Nat Rev Neurosci (2013) 2.21

Thalamic neurodegeneration in multiple sclerosis. Ann Neurol (2002) 2.20

Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2013) 2.20

Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain (2010) 2.19

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage (2010) 2.18

Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS. Neurology (2013) 2.18

Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 2.17

Whole brain resting-state analysis reveals decreased functional connectivity in major depression. Front Syst Neurosci (2010) 2.16

Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity. PLoS One (2010) 2.12

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol (2005) 2.10

DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage (2010) 2.10

Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci (2002) 2.10

MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08

Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol (2005) 2.07

Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler (2011) 2.07

Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med (2007) 2.06

Functional connectomics from resting-state fMRI. Trends Cogn Sci (2013) 2.05

Informatics and data mining tools and strategies for the human connectome project. Front Neuroinform (2011) 2.01

Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med (2010) 2.00

Fully Bayesian spatio-temporal modeling of FMRI data. IEEE Trans Med Imaging (2004) 1.98

Grey matter pathology in multiple sclerosis. Lancet Neurol (2008) 1.97

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet (2004) 1.93

Solid and gaseous cerebral microembolization during off-pump, on-pump, and open cardiac surgery procedures. J Thorac Cardiovasc Surg (2004) 1.93

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90

Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke (2006) 1.88

Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner. Neuroimage (2011) 1.88

Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab (2010) 1.85

The role of the posterior fusiform gyrus in reading. J Cogn Neurosci (2006) 1.85

Age-related changes in grey and white matter structure throughout adulthood. Neuroimage (2010) 1.85

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial. Lancet Neurol (2013) 1.84

Blood oxygenation level dependent contrast resting state networks are relevant to functional activity in the neocortical sensorimotor system. Exp Brain Res (2005) 1.84

Rapid modulation of GABA concentration in human sensorimotor cortex during motor learning. J Neurophysiol (2005) 1.83